PCN29 COST-EFFECTIVENESS OF MAINTENANCE RITUXIMAB TREATMENT AFTER SECOND LINE THERAPY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA IN SWEDEN

Autor: Kasteng, F, Erlanson, M, Hagberg, H, Kimby, E, Relander, T, Lundkvist, J
Zdroj: In Value in Health 2007 10(6):A331-A331
Databáze: ScienceDirect